Related Experiment Videos
Transurethral resection in regionally advanced bladder cancer
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, Cornell University Medical College, New York, New York.
The Urologic Clinics of North America
|November 1, 1992
Summary
Identifying patients who can benefit from conservative management for advanced bladder cancer is challenging. Further research is needed to determine tumor characteristics that predict successful outcomes with transurethral resection and chemotherapy.
Area of Science:
- Oncology
- Urology
Background:
- Regionally advanced bladder cancer requires effective disease control strategies.
- Transurethral resection (TUR) can potentially cure some patients with invasive bladder cancer.
- Early identification of patients suitable for conservative management is difficult.
Purpose of the Study:
- To evaluate the role of restaging transurethral resection in determining conservative management feasibility for advanced bladder cancer.
- To explore how transurethral resection might enhance chemotherapy response in select patients.
- To identify tumor characteristics associated with favorable outcomes in conservative management of regionally advanced bladder cancer.
Main Methods:
- Review of existing treatment modalities for advanced bladder cancer.
- Assessment of transurethral resection (TUR) as a diagnostic and therapeutic tool.
- Analysis of patient response to conservative management and chemotherapy.
Main Results:
- Transurethral resection (TUR) can indicate feasibility of conservative management and guide surgical decisions.
- In some cases, TUR may improve the effectiveness of chemotherapy.
- Identifying patients with potential for cure via conservative management remains a challenge.
Conclusions:
- Restaging transurethral resection (TUR) is valuable for treatment planning in advanced bladder cancer.
- Further research is essential to pinpoint tumor markers for successful conservative management.
- Optimizing treatment strategies requires understanding patient-specific tumor characteristics.